tiprankstipranks
Trending News
More News >
Lotus Pharmaceuticals (LTUS)
:LTUS
US Market
Advertisement

Lotus Pharmaceuticals (LTUS) Financial Statements

Compare
4 Followers

Lotus Pharmaceuticals Financial Overview

Lotus Pharmaceuticals's market cap is currently $275.38K. The company's EPS TTM is $0; its P/E ratio is ―; Lotus Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -18.81K$ -21.11K$ -30.41K$ -6.28K$ -21.83K
EBITDA$ -18.81K$ -21.11K$ -30.41K$ -6.28K$ -21.83K
Net Income$ -18.81K$ -21.11K$ -30.41K$ -6.28K$ -21.83K
Balance Sheet
Cash & Short-Term Investments$ 1.90K$ 1.15K$ 7.67K$ 1.74K$ 31.00
Total Assets$ 5.68K$ 4.81K$ 7.67K$ 1.74K$ 8.54K
Total Debt$ 116.68K$ 96.80K$ 75.64K$ 39.30K$ 30.37K
Net Debt$ 114.78K$ 95.65K$ 67.97K$ 37.55K$ 30.34K
Total Liabilities$ 116.68K$ 97.00K$ 75.64K$ 39.30K$ 30.37K
Stockholders' Equity$ -111.00K$ -92.19K$ -67.97K$ -37.55K$ -21.83K
Cash Flow
Free Cash Flow$ -19.13K$ -23.82K$ -30.41K$ -6.28K$ -21.83K
Operating Cash Flow$ -19.13K$ -23.82K$ -30.41K$ -6.28K$ -21.83K
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ 8.51K
Financing Cash Flow$ 19.88K$ 17.30K$ 36.34K$ 8.00K$ 30.37K
Currency in USD

Lotus Pharmaceuticals Earnings and Revenue History

Lotus Pharmaceuticals Debt to Assets

Lotus Pharmaceuticals Cash Flow

Lotus Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis